Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1995
06/14/1995EP0657426A2 Tricyclic pyrrole derivatives
06/14/1995EP0656944A1 Human melanocyte stimulating hormone receptor
06/14/1995EP0656782A1 Nutritional product for persons having a neurological injury
06/14/1995EP0656775A1 Sustained release tablets containing bupropion
06/14/1995CN1103580A New use
06/14/1995CA2135861A1 Oxazolidin-2-one derivatives
06/13/1995US5424456 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof
06/13/1995US5424451 Process for preparing aminoalkylcarbamic esters of eseroline
06/13/1995US5424447 Inhibitors of nitric oxide formation from arginine
06/13/1995US5424441 Nootropic, antiepileptic agents
06/13/1995US5424425 Analgesics, antidepressants, hypotensive agent and treats irritable bowel syndrome and congestive heart failure
06/13/1995US5424328 Treatment of central nervous system disorders
06/13/1995US5424318 Treating dementia, cerebrovascular diseases
06/13/1995US5424314 Anti-anoxic
06/13/1995US5424313 Bibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivatives
06/13/1995US5424312 Treating central nervous system disorders, high blood pressure
06/13/1995US5424301 Cognition activators
06/13/1995US5424294 Modified gangliosides and the functional derivatives thereof
06/13/1995US5424057 Medical diagnosis
06/13/1995CA1335897C (e)-2-(p-fluorophenethyl)-3-fluoroallylamine
06/11/1995CA2137524A1 Aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5- carboxylic acid esters
06/11/1995CA2137519A1 4-phenyl-3-substituted 1,4-dihydropyridine esters
06/11/1995CA2137518A1 Dihydropyridines with substituted esters
06/10/1995CA2137613A1 Process for the preparation of epibatidine
06/10/1995CA2137611A1 Epi-epibatidine derivatives
06/08/1995WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
06/08/1995WO1995015338A1 Chaperonin 10
06/08/1995WO1995015327A1 N-substituted azabicycloalkane derivatives as neuroleptika asf
06/08/1995WO1995015318A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
06/08/1995WO1995015317A1 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders
06/08/1995WO1995015316A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/08/1995WO1995015315A1 1,5-diphenyl pyrazole compounds for treatment of inflammation
06/08/1995WO1995015312A1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
06/08/1995WO1995015311A1 Tachykinin antagonists
06/08/1995WO1995015310A1 Prolyl endopeptidase inhibitors
06/08/1995WO1995015179A1 Method of treating intestinal disorders
06/08/1995WO1995015173A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995WO1995015147A1 Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances
06/08/1995DE4421433C1 Transdermal therapeutic system for treatment of, e.g., hypertension
06/08/1995CA2177994A1 Tachykinin antagonists
06/08/1995CA2177825A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995CA2177824A1 1,5-diphenyl pyrazole compounds for treatment of inflammation
06/08/1995CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995CA2177574A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
06/08/1995CA2177573A1 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders
06/08/1995CA2177570A1 Method of treating intestinal disorders
06/07/1995EP0656362A1 Novel compounds
06/07/1995EP0656359A1 Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts and compositionsand methods of use thereof
06/07/1995EP0656354A1 Substituted N-piperidino 3-pyrazolecarboxamide
06/07/1995EP0656345A1 Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases
06/07/1995EP0656209A2 Melatonin derivatives for use in treating desynchronization disorders
06/07/1995EP0656069A1 Inhibitors of cell proliferation, their preparation and use
06/07/1995EP0656062A1 Dorsal tissue affecting factor and compositions
06/07/1995EP0656015A1 New nimesulide salt cyclodextrin inclusion complexes
06/07/1995EP0656007A1 Opioid receptor genes
06/07/1995EP0656002A1 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
06/07/1995EP0656001A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
06/07/1995EP0655996A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
06/07/1995EP0616532A4 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease.
06/07/1995EP0603312A4 Novel gaba a? receptor with steroid binding sites.
06/07/1995CN1103289A Opioid formulations having extended controlled release
06/07/1995CN1028756C Pryidyl-and pyrimidyl derivatives
06/07/1995CA2137443A1 Thienothiazinderivatives, process for their preparation and their use
06/06/1995US5422374 Oral administration of ubidecarenone
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422358 Muscarinic receptor antagonists
06/06/1995US5422354 Quinuclidine derivatives
06/06/1995US5422353 Tetrahydropyridine derivatives
06/06/1995US5422102 Diclofenac or salt with nonionic polymer of hydroxypropyl and/or hydroxyethyl cellulose; percutaneous adsorption
06/06/1995CA1335813C Administration of monoamine acridines in cholinergic neuronal deficit states
06/04/1995CA2137029A1 Novel compounds
06/04/1995CA2137028A1 Pharmaceutical compounds
06/04/1995CA2136904A1 Excitatory amino acid receptor antagonists
06/02/1995CA2136789A1 Methods of inhibiting the effects of amyloidogenic proteins
06/01/1995WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
06/01/1995WO1995014693A1 Imidazolinobenzodiazepines
06/01/1995WO1995014691A1 NOVEL 9-HYDROXY-PYRIDO[1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
06/01/1995WO1995014682A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
06/01/1995WO1995014670A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014478A1 Purine compositions and methods for administration
06/01/1995WO1995014476A1 The use of an ester of inositoltrisphosphate for the preparing of an analgetic medicament
06/01/1995WO1995014467A1 Therapeutic guanidines
06/01/1995WO1995014461A1 Therapeutic substituted guanidines
06/01/1995WO1995014460A1 Opioid formulations for treating pain
06/01/1995CA2177084A1 Therapeutic guanidines
06/01/1995CA2177081A1 Therapeutic substituted guanidines
06/01/1995CA2177074A1 P53-binding polypeptides and polynucleotides encoding same
06/01/1995CA2176017A1 Imidazolinobenzodiazepines
06/01/1995CA2175828A1 Purine compositions and methods for administration
06/01/1995CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
05/1995
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655449A1 A process for preparing N-( 2-pyrimidyl) piperazinyl butyl imides
05/31/1995EP0655445A1 1,3,4-oxadiazol-2(3H)-one Derivates, their preparation and their use as monoamine oxidase inhibitors
05/31/1995EP0655442A1 Piperazine derivatives as Tachykinin antagonists
05/31/1995EP0655440A2 1-Aminoethylindoles
05/31/1995EP0655247A1 Use of vincristine for the evaluation of substances at the neuroral level
05/31/1995EP0655243A2 Melatonin derivatives for use in treating sleep disorders
05/31/1995EP0655055A1 Tachykinin antagonists
05/31/1995EP0576420B1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
1 ... 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 ... 1833